TOPIRAMATE

TOPIRAMATE was reported 50793 times

TOPIRAMATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 83 0.5570
1 VISUAL PERSEVERATION 72 0.4898
2 MITOCHONDRIAL DNA MUTATION 35 0.4070
3 MYOKYMIA 45 0.3719
4 ACUTE MYOPIA 60 0.3297
5 NEW ONSET REFRACTORY STATUS EPILEPTICUS 33 0.3000
6 FLAT ANTERIOR CHAMBER OF EYE 53 0.2961
7 CHOROIDAL EFFUSION 184 0.2291
8 NEOVASCULARISATION 52 0.1977
9 FACET JOINT SYNDROME 625 0.1918
10 MULTIPLE-DRUG RESISTANCE 585 0.1885
11 EPILEPTIC ENCEPHALOPATHY 41 0.1839
12 ANGLE CLOSURE GLAUCOMA 422 0.1652
13 ACIDOSIS HYPERCHLORAEMIC 96 0.1616
14 HYPOCHOLESTEROLAEMIA 54 0.1530
15 MEDICATION OVERUSE HEADACHE 120 0.1402
16 PERIPHERAL VENOUS DISEASE 557 0.1363
17 ONYCHOMADESIS 563 0.1340
18 MIGRAINE WITHOUT AURA 39 0.1304
19 OVERLAP SYNDROME 90 0.1286
20 RHEUMATIC FEVER 537 0.1203
21 BLEPHAROSPASM 731 0.1160
22 PHONOPHOBIA 53 0.1152
23 CHOROIDAL DETACHMENT 59 0.1063
24 RENAL TUBULAR ACIDOSIS 231 0.1058
25 BREAST CANCER STAGE III 640 0.0987
26 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 675 0.0941
27 HYPOHIDROSIS 47 0.0938
28 MYOCLONIC EPILEPSY 142 0.0935
29 FINGER DEFORMITY 442 0.0912
30 ONYCHOMYCOSIS 394 0.0897
31 MYOPIA 210 0.0881
32 HYPERAMMONAEMIC ENCEPHALOPATHY 152 0.0874
33 INFANTILE SPASMS 63 0.0871
34 DUODENAL ULCER PERFORATION 647 0.0869
35 LUPUS VULGARIS 104 0.0825
36 CHANGE IN SEIZURE PRESENTATION 51 0.0788
37 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 44 0.0784
38 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 36 0.0769
39 FOLLICULITIS 799 0.0761
40 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 49 0.0755
41 DISLOCATION OF VERTEBRA 172 0.0753
42 NAIL DISORDER 650 0.0742
43 WOUND INFECTION 804 0.0733
44 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 38 0.0709
45 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 146 0.0704
46 C-REACTIVE PROTEIN ABNORMAL 444 0.0691
47 HEAT STROKE 104 0.0683
48 PRODUCT LABEL CONFUSION 397 0.0680
49 MUSCLE INJURY 556 0.0670
50 PROPOFOL INFUSION SYNDROME 47 0.0667
51 INFUSION SITE REACTION 198 0.0662
52 PEMPHIGUS 814 0.0650
53 LIP DRY 591 0.0650
54 BURSITIS 769 0.0633
55 CLEFT LIP AND PALATE 70 0.0626
56 LIVE BIRTH 514 0.0614
57 HELICOBACTER INFECTION 615 0.0598
58 GRIP STRENGTH DECREASED 525 0.0596
59 CLEFT LIP 52 0.0594
60 TONIC CONVULSION 84 0.0592
61 X-RAY ABNORMAL 104 0.0581
62 FANCONI SYNDROME 82 0.0580
63 ATONIC SEIZURES 49 0.0570
64 HYPERCHOLESTEROLAEMIA 544 0.0563
65 STATUS EPILEPTICUS 621 0.0549
66 HAND DEFORMITY 702 0.0535
67 SEIZURE CLUSTER 44 0.0531
68 BACK INJURY 571 0.0525
69 JOINT RANGE OF MOTION DECREASED 683 0.0509
70 SWOLLEN JOINT COUNT INCREASED 160 0.0501
71 DEEP VEIN THROMBOSIS POSTOPERATIVE 99 0.0494
72 SYNOVITIS 865 0.0479
73 EPILEPSY 1466 0.0479
74 PORPHYRIA ACUTE 68 0.0474
75 PERICARDITIS 794 0.0472
76 NECROTISING COLITIS 59 0.0465
77 SOFT TISSUE INJURY 35 0.0462
78 PETIT MAL EPILEPSY 236 0.0462
79 HYPOSPADIAS 96 0.0461
80 POST-TRAUMATIC NECK SYNDROME 37 0.0457
81 HYPERAMMONAEMIA 222 0.0443
82 INTELLECTUAL DISABILITY 66 0.0434
83 COMPLEX PARTIAL SEIZURES 48 0.0432
84 COELIAC DISEASE 422 0.0430
85 PARTIAL SEIZURES 219 0.0418
86 PSYCHOGENIC SEIZURE 39 0.0417
87 C-REACTIVE PROTEIN 38 0.0410
88 CONGENITAL ANOMALY 307 0.0396
89 FOCAL DYSCOGNITIVE SEIZURES 45 0.0395
90 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 104 0.0391
91 TASTE DISORDER 783 0.0386
92 OBESITY 580 0.0364
93 FIBROMYALGIA 879 0.0361
94 GLOSSODYNIA 795 0.0355
95 CLUSTER HEADACHE 47 0.0344
96 PRODUCT USED FOR UNKNOWN INDICATION 43 0.0342
97 WOUND 955 0.0341
98 CEREBRAL VENOUS THROMBOSIS 59 0.0325
99 RETINITIS 55 0.0318
100 DYSMORPHISM 75 0.0318
101 IRRITABLE BOWEL SYNDROME 680 0.0317
102 STERNAL FRACTURE 39 0.0316
103 ANTICONVULSANT DRUG LEVEL INCREASED 51 0.0316
104 RHEUMATOID FACTOR POSITIVE 182 0.0315
105 FOETAL MALFORMATION 34 0.0313
106 BONE EROSION 107 0.0302
107 BRONCHIAL HYPERREACTIVITY 36 0.0299
108 ISCHAEMIC CEREBRAL INFARCTION 33 0.0284
109 ADVERSE REACTION 371 0.0280
110 SYSTEMIC LUPUS ERYTHEMATOSUS 993 0.0279
111 AURA 52 0.0279
112 NEPHROCALCINOSIS 33 0.0278
113 NORMAL NEWBORN 151 0.0278
114 RESPIRATORY ALKALOSIS 45 0.0277
115 CONTRAINDICATED PRODUCT ADMINISTERED 832 0.0275
116 MIGRAINE 2555 0.0267
117 PARADOXICAL DRUG REACTION 98 0.0266
118 MIGRAINE WITH AURA 72 0.0265
119 SUBSTANCE USE 41 0.0263
120 TYPE 2 DIABETES MELLITUS 885 0.0263
121 SEDATION 682 0.0260
122 GENERALISED TONIC-CLONIC SEIZURE 419 0.0253
123 CORNEAL OEDEMA 56 0.0250
124 LIVER FUNCTION TEST INCREASED 529 0.0246
125 ATAXIA 291 0.0245
126 LIBIDO INCREASED 49 0.0241
127 PSYCHOMOTOR SKILLS IMPAIRED 63 0.0240
128 BEHAVIOUR DISORDER 127 0.0235
129 LIVER INJURY 568 0.0231
130 DRUG WITHDRAWAL CONVULSIONS 41 0.0230
131 MACULOPATHY 81 0.0228
132 CALCULUS URINARY 35 0.0227
133 ELECTROENCEPHALOGRAM ABNORMAL 71 0.0225
134 GAIT INABILITY 748 0.0224
135 DRUG INTOLERANCE 2143 0.0222
136 ACCIDENTAL DEATH 40 0.0215
137 PSYCHOMOTOR RETARDATION 60 0.0213
138 GENE MUTATION 42 0.0212
139 PSORIATIC ARTHROPATHY 854 0.0210
140 SINUS PAIN 49 0.0210
141 NYSTAGMUS 111 0.0209
142 BLOOD BICARBONATE DECREASED 39 0.0206
143 AMMONIA INCREASED 105 0.0206
144 REBOUND ACID HYPERSECRETION 61 0.0201
145 DRUG TOLERANCE 102 0.0201
146 BRADYPHRENIA 130 0.0199
147 AUTONOMIC NERVOUS SYSTEM IMBALANCE 58 0.0198
148 SEIZURE 2293 0.0198
149 NIGHT SWEATS 619 0.0192
150 C-REACTIVE PROTEIN INCREASED 698 0.0192
151 COMMUNICATION DISORDER 73 0.0191
152 CLUMSINESS 52 0.0190
153 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1045 0.0190
154 DRUG TOLERANCE DECREASED 53 0.0189
155 PERSONALITY DISORDER 49 0.0187
156 ULCER HAEMORRHAGE 125 0.0185
157 NEPHROLITHIASIS 836 0.0182
158 BREAST DISORDER 37 0.0181
159 DRUG RESISTANCE 462 0.0180
160 SUSPECTED SUICIDE 84 0.0179
161 MYOCLONUS 213 0.0178
162 IMPAIRED HEALING 582 0.0177
163 SMALL FOR DATES BABY 87 0.0175
164 PRESCRIBED OVERDOSE 338 0.0174
165 WRONG PATIENT RECEIVED PRODUCT 51 0.0174
166 AUTISM SPECTRUM DISORDER 95 0.0172
167 SEROTONIN SYNDROME 330 0.0172
168 OSTEOARTHRITIS 723 0.0170
169 HOSTILITY 43 0.0169
170 PRE-EXISTING CONDITION IMPROVED 105 0.0168
171 HEPATITIS 430 0.0168
172 WHEEZING 986 0.0166
173 MATERNAL DRUGS AFFECTING FOETUS 127 0.0165
174 THERAPEUTIC PRODUCT EFFECT DECREASED 737 0.0164
175 NECK PAIN 885 0.0158
176 BLOOD CHOLESTEROL INCREASED 737 0.0158
177 TREATMENT FAILURE 1309 0.0158
178 SLOW SPEECH 38 0.0156
179 BREAST CANCER STAGE II 130 0.0156
180 METABOLIC ACIDOSIS 497 0.0155
181 GASTROOESOPHAGEAL REFLUX DISEASE 1245 0.0155
182 BRAIN HERNIATION 46 0.0154
183 GRAND MAL CONVULSION 142 0.0154
184 EXOSTOSIS 140 0.0153
185 STARING 37 0.0153
186 COMPLETED SUICIDE 1275 0.0153
187 LOWER RESPIRATORY TRACT INFECTION 694 0.0152
188 DRUG-INDUCED LIVER INJURY 478 0.0152
189 IDIOPATHIC INTRACRANIAL HYPERTENSION 34 0.0151
190 COGNITIVE DISORDER 706 0.0151
191 CONCUSSION 117 0.0151
192 SOMNAMBULISM 97 0.0148
193 NEPHROGENIC ANAEMIA 68 0.0147
194 PRESCRIBED UNDERDOSE 292 0.0146
195 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 249 0.0145
196 LEARNING DISORDER 35 0.0145
197 SPEECH DISORDER DEVELOPMENTAL 41 0.0143
198 HYPERTHERMIA 109 0.0143
199 PRIAPISM 49 0.0142
200 MATERNAL EXPOSURE DURING PREGNANCY 1254 0.0141
201 PERSECUTORY DELUSION 35 0.0140
202 INFLAMMATION 723 0.0140
203 IRIDOCYCLITIS 44 0.0139
204 TEARFULNESS 59 0.0137
205 PUSTULAR PSORIASIS 47 0.0137
206 LUPUS-LIKE SYNDROME 124 0.0137
207 ARTHROPATHY 749 0.0135
208 AUTOIMMUNE DISORDER 131 0.0134
209 POST-TRAUMATIC STRESS DISORDER 89 0.0133
210 SUICIDAL BEHAVIOUR 55 0.0132
211 LOWER LIMB FRACTURE 254 0.0132
212 SLEEP DISORDER 928 0.0131
213 ENURESIS 53 0.0131
214 HYPERACUSIS 48 0.0129
215 BLISTER 722 0.0128
216 INTENTIONAL PRODUCT USE ISSUE 1095 0.0125
217 PRODUCT ADMINISTRATION INTERRUPTED 98 0.0125
218 MAJOR DEPRESSION 91 0.0124
219 GAMBLING DISORDER 33 0.0122
220 INFUSION RELATED REACTION 809 0.0122
221 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 864 0.0121
222 LUNG DISORDER 593 0.0121
223 AFFECTIVE DISORDER 95 0.0121
224 TOXIC ENCEPHALOPATHY 61 0.0120
225 VISUAL FIELD DEFECT 87 0.0120
226 RED BLOOD CELL SEDIMENTATION RATE INCREASED 133 0.0120
227 EYE INJURY 36 0.0118
228 NIGHTMARE 407 0.0117
229 DRY MOUTH 954 0.0117
230 CHRONIC SINUSITIS 44 0.0117
231 PSYCHOTIC DISORDER 345 0.0117
232 CONVULSION 668 0.0117
233 MEMORY IMPAIRMENT 1601 0.0116
234 PHOTOPHOBIA 219 0.0116
235 PARAESTHESIA 1828 0.0116
236 INJURY 813 0.0116
237 SPONDYLITIS 42 0.0115
238 MOBILITY DECREASED 828 0.0115
239 FOETAL EXPOSURE DURING PREGNANCY 933 0.0115
240 IMPAIRED GASTRIC EMPTYING 156 0.0114
241 ANTINUCLEAR ANTIBODY POSITIVE 37 0.0114
242 EXPOSURE DURING PREGNANCY 704 0.0113
243 AGGRESSION 562 0.0112
244 HEPATIC ENZYME INCREASED 762 0.0112
245 SCIATICA 177 0.0111
246 STOMATITIS 669 0.0110
247 BLOOD LACTIC ACID INCREASED 58 0.0110
248 SNORING 41 0.0108
249 WALKING AID USER 71 0.0108
250 SOCIAL AVOIDANT BEHAVIOUR 62 0.0107
251 MUSCULOSKELETAL PAIN 561 0.0107
252 CATATONIA 56 0.0107
253 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 181 0.0106
254 MATERNAL EXPOSURE TIMING UNSPECIFIED 40 0.0106
255 BLOOD PROLACTIN INCREASED 50 0.0106
256 PRODUCT USE IN UNAPPROVED INDICATION 2627 0.0106
257 EAR PAIN 206 0.0106
258 BIPOLAR DISORDER 115 0.0106
259 EYE MOVEMENT DISORDER 72 0.0105
260 SWELLING 981 0.0105
261 VENTRICULAR SEPTAL DEFECT 60 0.0105
262 VITAMIN D DEFICIENCY 102 0.0104
263 APHASIA 315 0.0104
264 THERAPY NON-RESPONDER 466 0.0104
265 SWOLLEN TONGUE 321 0.0103
266 HYPOAESTHESIA 1535 0.0102
267 HALLUCINATIONS, MIXED 43 0.0102
268 SKIN ODOUR ABNORMAL 40 0.0102
269 APATHY 147 0.0101
270 APNOEA 78 0.0100
271 ATRIAL SEPTAL DEFECT 83 0.0099
272 DYSPEPSIA 975 0.0099
273 URINE ABNORMALITY 45 0.0099
274 HYPERNATRAEMIA 49 0.0098
275 IMMUNE THROMBOCYTOPENIA 45 0.0098
276 SELF-INJURIOUS IDEATION 41 0.0098
277 ENCEPHALOPATHY 239 0.0097
278 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 63 0.0097
279 TRIGEMINAL NEURALGIA 39 0.0097
280 HALLUCINATION, AUDITORY 153 0.0096
281 NEUROLEPTIC MALIGNANT SYNDROME 114 0.0096
282 CONFUSIONAL STATE 1552 0.0096
283 DYSPHEMIA 42 0.0096
284 DEVELOPMENTAL DELAY 86 0.0095
285 DISTURBANCE IN ATTENTION 513 0.0095
286 HYPERREFLEXIA 33 0.0095
287 PRODUCT SUBSTITUTION ISSUE 544 0.0094
288 DYSARTHRIA 355 0.0094
289 DRUG INTERACTION 1483 0.0093
290 PARANOIA 161 0.0093
291 PATENT DUCTUS ARTERIOSUS 37 0.0093
292 THERAPY PARTIAL RESPONDER 145 0.0093
293 PULMONARY FIBROSIS 178 0.0093
294 ACIDOSIS 70 0.0092
295 BRADYKINESIA 54 0.0091
296 HEAD DISCOMFORT 161 0.0091
297 HYPOTHERMIA 92 0.0091
298 DIPLOPIA 234 0.0090
299 CHRONIC KIDNEY DISEASE 679 0.0089
300 BUNDLE BRANCH BLOCK RIGHT 41 0.0089
301 BLOOD PRESSURE DIASTOLIC INCREASED 41 0.0089
302 TENSION HEADACHE 38 0.0088
303 HYPOTONIA 88 0.0088
304 LOW BIRTH WEIGHT BABY 70 0.0088
305 ABNORMAL LOSS OF WEIGHT 60 0.0088
306 GASTROINTESTINAL DISORDER 781 0.0087
307 TOXICITY TO VARIOUS AGENTS 1469 0.0087
308 DEPRESSION 1978 0.0087
309 RASH VESICULAR 42 0.0087
310 RHEUMATOID ARTHRITIS 984 0.0087
311 MANIA 141 0.0086
312 PRODUCT USE ISSUE 1608 0.0085
313 RHINITIS ALLERGIC 38 0.0085
314 CEREBRAL ATROPHY 34 0.0085
315 ILL-DEFINED DISORDER 513 0.0084
316 MUSCULAR WEAKNESS 959 0.0084
317 SUSPECTED OFF LABEL USE 38 0.0084
318 ASPIRATION 92 0.0084
319 COORDINATION ABNORMAL 117 0.0084
320 AMNESIA 545 0.0084
321 MUSCULOSKELETAL STIFFNESS 724 0.0083
322 FOETAL GROWTH RESTRICTION 50 0.0082
323 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 394 0.0082
324 HEPATIC CIRRHOSIS 154 0.0082
325 INCOHERENT 53 0.0082
326 GENERAL PHYSICAL HEALTH DETERIORATION 947 0.0082
327 HALLUCINATION, VISUAL 172 0.0081
328 HAEMODYNAMIC INSTABILITY 62 0.0081
329 DISCOMFORT 496 0.0081
330 DELUSION 126 0.0081
331 OBSTRUCTIVE AIRWAYS DISORDER 90 0.0081
332 BRAIN INJURY 81 0.0081
333 WEIGHT INCREASED 1801 0.0080
334 SOMNOLENCE 1618 0.0080
335 SUICIDAL IDEATION 733 0.0080
336 BRAIN OEDEMA 101 0.0080
337 MENTAL IMPAIRMENT 193 0.0080
338 STILLBIRTH 38 0.0079
339 DRUG LEVEL DECREASED 80 0.0079
340 ATTENTION DEFICIT HYPERACTIVITY DISORDER 33 0.0078
341 DELIRIUM 271 0.0078
342 IRRITABILITY 466 0.0077
343 MUSCLE TWITCHING 178 0.0077
344 ROAD TRAFFIC ACCIDENT 323 0.0077
345 DEPRESSED LEVEL OF CONSCIOUSNESS 302 0.0076
346 HYPERVENTILATION 44 0.0076
347 IRON DEFICIENCY 34 0.0076
348 ANAL INCONTINENCE 68 0.0076
349 HEMIPARESIS 127 0.0075
350 SPUTUM DISCOLOURED 71 0.0075
351 SPEECH DISORDER 392 0.0075
352 BRAIN FOG 117 0.0075
353 ABORTION SPONTANEOUS 299 0.0075
354 ELECTROCARDIOGRAM QT PROLONGED 268 0.0074
355 EOSINOPHIL COUNT INCREASED 62 0.0074
356 ANURIA 64 0.0074
357 FEELING DRUNK 55 0.0074
358 MIDDLE INSOMNIA 138 0.0074
359 TEMPERATURE INTOLERANCE 76 0.0074
360 CONDITION AGGRAVATED 2218 0.0073
361 SUICIDE ATTEMPT 440 0.0072
362 FACIAL PAIN 64 0.0072
363 MOTOR DYSFUNCTION 73 0.0072
364 INTENTIONAL OVERDOSE 459 0.0071
365 ALOPECIA 1404 0.0071
366 RESPIRATORY ARREST 196 0.0071
367 ABNORMAL BEHAVIOUR 280 0.0071
368 FOOT DEFORMITY 78 0.0070
369 HYPERTONIA 40 0.0070
370 SLUGGISHNESS 71 0.0070
371 SENSORY LOSS 56 0.0069
372 MYDRIASIS 89 0.0069
373 POISONING 87 0.0069
374 UPPER-AIRWAY COUGH SYNDROME 57 0.0069
375 DRUG TOXICITY 94 0.0069
376 POLYARTHRITIS 36 0.0068
377 JOINT SWELLING 823 0.0068
378 DYSPHONIA 397 0.0068
379 PSYCHIATRIC SYMPTOM 50 0.0068
380 DRUG LEVEL INCREASED 112 0.0068
381 EAR INFECTION 180 0.0068
382 ANGIOEDEMA 299 0.0068
383 AFFECT LABILITY 65 0.0067
384 DEPRESSED MOOD 356 0.0067
385 INJECTION SITE REACTION 463 0.0067
386 EAR DISCOMFORT 69 0.0067
387 BACK DISORDER 109 0.0067
388 ABDOMINAL DISCOMFORT 1120 0.0067
389 DECREASED INTEREST 39 0.0066
390 MOOD ALTERED 180 0.0066
391 ABDOMINAL DISTENSION 688 0.0066
392 ANGER 222 0.0066
393 DISORIENTATION 260 0.0066
394 INITIAL INSOMNIA 67 0.0065
395 OFF LABEL USE 5701 0.0065
396 CARDIO-RESPIRATORY ARREST 272 0.0065
397 POOR QUALITY SLEEP 139 0.0065
398 SLEEP APNOEA SYNDROME 123 0.0064
399 DYSTONIA 125 0.0064
400 RESTLESS LEGS SYNDROME 117 0.0064
401 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 46 0.0064
402 DYSGRAPHIA 42 0.0064
403 PAROSMIA 48 0.0064
404 RESPIRATORY DISORDER 190 0.0063
405 INTRAOCULAR PRESSURE INCREASED 81 0.0063
406 IMPAIRED DRIVING ABILITY 72 0.0063
407 SWELLING FACE 412 0.0063
408 PERIPHERAL SWELLING 974 0.0063
409 DISABILITY 125 0.0063
410 PNEUMONIA ASPIRATION 157 0.0063
411 SCREAMING 40 0.0063
412 END STAGE RENAL DISEASE 114 0.0062
413 INFUSION SITE SWELLING 39 0.0062
414 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 159 0.0062
415 DRUG LEVEL BELOW THERAPEUTIC 34 0.0062
416 HYDRONEPHROSIS 46 0.0061
417 UNRESPONSIVE TO STIMULI 158 0.0061
418 SEASONAL ALLERGY 86 0.0061
419 HYPERTRANSAMINASAEMIA 42 0.0060
420 HYPERSOMNIA 173 0.0060
421 HYPOKINESIA 87 0.0060
422 EYE PAIN 338 0.0060
423 VITAMIN D DECREASED 51 0.0060
424 PSYCHOMOTOR HYPERACTIVITY 99 0.0060
425 ABDOMINAL PAIN UPPER 1228 0.0060
426 HYPOPHOSPHATAEMIA 44 0.0059
427 INTERVERTEBRAL DISC DEGENERATION 55 0.0059
428 URTICARIA 994 0.0059
429 REBOUND EFFECT 67 0.0059
430 ACUTE HEPATIC FAILURE 81 0.0059
431 TREMOR 982 0.0059
432 TROPONIN INCREASED 45 0.0059
433 JOINT STIFFNESS 155 0.0059
434 HEADACHE 3701 0.0059
435 THINKING ABNORMAL 109 0.0058
436 PRODUCT QUALITY ISSUE 792 0.0058
437 SALIVARY HYPERSECRETION 58 0.0058
438 GALACTORRHOEA 37 0.0058
439 AGITATION 422 0.0057
440 MOOD SWINGS 183 0.0057
441 INSOMNIA 1526 0.0057
442 HYPOKALAEMIA 263 0.0057
443 DECREASED APPETITE 1319 0.0057
444 CENTRAL NERVOUS SYSTEM LESION 78 0.0057
445 JOINT DISLOCATION 60 0.0057
446 HYPERSENSITIVITY 1052 0.0057
447 MUSCLE SPASMS 1036 0.0056
448 PREGNANCY 113 0.0056
449 SINUS TACHYCARDIA 80 0.0056
450 MENTAL DISORDER 245 0.0056
451 MULTIPLE ALLERGIES 44 0.0056
452 SINUSITIS 575 0.0056
453 FORMICATION 39 0.0056
454 NEURALGIA 136 0.0056
455 DRUG EXPOSURE DURING PREGNANCY 190 0.0056
456 TINNITUS 256 0.0056
457 INTENTIONAL SELF-INJURY 112 0.0055
458 HEMIPLEGIA 46 0.0055
459 OVARIAN CYST 55 0.0055
460 BODY TEMPERATURE DECREASED 54 0.0055
461 DISSOCIATION 42 0.0055
462 EATING DISORDER 116 0.0054
463 APHTHOUS ULCER 42 0.0054
464 SINUS DISORDER 107 0.0054
465 BRADYCARDIA 286 0.0054
466 CONTUSION 519 0.0054
467 LETHARGY 310 0.0054
468 VERTIGO 328 0.0054
469 RENAL PAIN 57 0.0054
470 PETECHIAE 56 0.0054
471 DRUG INEFFECTIVE 7062 0.0054
472 SPINAL OSTEOARTHRITIS 47 0.0053
473 MYOSITIS 48 0.0053
474 WEIGHT DECREASED 1487 0.0053
475 OSTEOPOROSIS 219 0.0053
476 WITHDRAWAL SYNDROME 223 0.0053
477 NERVE INJURY 59 0.0053
478 URINARY INCONTINENCE 157 0.0053
479 BODY TEMPERATURE INCREASED 108 0.0053
480 HYPERTENSION 1117 0.0053
481 HYPERHIDROSIS 679 0.0053
482 NASOPHARYNGITIS 968 0.0052
483 DYSKINESIA 213 0.0052
484 LEFT VENTRICULAR DYSFUNCTION 35 0.0052
485 PHOTOPSIA 33 0.0052
486 HAIR DISORDER 43 0.0052
487 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 46 0.0052
488 PYELONEPHRITIS 45 0.0052
489 FALL 1728 0.0052
490 AMENORRHOEA 91 0.0052
491 TREATMENT NONCOMPLIANCE 283 0.0052
492 NEPHROPATHY TOXIC 58 0.0052
493 RENAL INJURY 153 0.0051
494 PHOTOSENSITIVITY REACTION 85 0.0051
495 CRYING 187 0.0051
496 ALTERED STATE OF CONSCIOUSNESS 111 0.0051
497 EYELID PTOSIS 52 0.0051
498 GAIT DISTURBANCE 979 0.0051
499 SENSORY DISTURBANCE 82 0.0051
500 OBSESSIVE-COMPULSIVE DISORDER 41 0.0051
501 INFUSION SITE ERYTHEMA 43 0.0051
502 DECREASED ACTIVITY 55 0.0051
503 BALANCE DISORDER 440 0.0051
504 OSTEOPENIA 77 0.0051
505 OPTIC NEURITIS 46 0.0051
506 THYROID DISORDER 78 0.0051
507 UVEITIS 68 0.0050
508 IMPAIRED QUALITY OF LIFE 72 0.0050
509 PARAESTHESIA ORAL 71 0.0049
510 DYSSTASIA 143 0.0049
511 IMMUNODEFICIENCY 73 0.0049
512 RETINAL DETACHMENT 45 0.0049
513 DIZZINESS 2441 0.0049
514 COLITIS ISCHAEMIC 33 0.0049
515 RESTLESSNESS 179 0.0049
516 MUSCLE SPASTICITY 60 0.0049
517 RIB FRACTURE 100 0.0049
518 FACIAL PARALYSIS 41 0.0048
519 HEAD INJURY 152 0.0048
520 TUBULOINTERSTITIAL NEPHRITIS 90 0.0048
521 INCORRECT PRODUCT ADMINISTRATION DURATION 104 0.0048
522 ENCEPHALITIS 33 0.0048
523 COMA 227 0.0048
524 LIGAMENT SPRAIN 47 0.0047
525 ECONOMIC PROBLEM 72 0.0047
526 BLINDNESS TRANSIENT 35 0.0047
527 SCRATCH 50 0.0047
528 CANDIDA INFECTION 80 0.0047
529 ASTHMA 535 0.0047
530 INCONTINENCE 50 0.0047
531 PANIC ATTACK 172 0.0047
532 TACHYPNOEA 64 0.0047
533 DENTAL CARIES 52 0.0047
534 FOOT FRACTURE 89 0.0047
535 VOMITING 2197 0.0047
536 GENERAL SYMPTOM 35 0.0047
537 SUBSTANCE ABUSE 38 0.0047
538 SINUS BRADYCARDIA 45 0.0047
539 BLOOD CREATINE PHOSPHOKINASE INCREASED 134 0.0047
540 MYOCARDITIS 53 0.0046
541 BLOOD POTASSIUM DECREASED 139 0.0046
542 ADRENAL INSUFFICIENCY 56 0.0046
543 DRUG ABUSE 384 0.0046
544 RHINITIS 37 0.0046
545 EUPHORIC MOOD 47 0.0046
546 DERMATITIS CONTACT 52 0.0046
547 EXTRAPYRAMIDAL DISORDER 113 0.0045
548 ANXIETY 1294 0.0045
549 VISION BLURRED 624 0.0045
550 THIRST 81 0.0045
551 WEIGHT FLUCTUATION 47 0.0045
552 PAIN IN EXTREMITY 1322 0.0045
553 HALLUCINATION 338 0.0045
554 MEDICATION ERROR 249 0.0045
555 BLINDNESS 182 0.0045
556 UNDERDOSE 326 0.0045
557 CEREBRAL DISORDER 33 0.0045
558 TOOTH FRACTURE 49 0.0044
559 PHARYNGITIS STREPTOCOCCAL 48 0.0044
560 CARDIAC ARREST 366 0.0044
561 BLADDER DISORDER 44 0.0044
562 ACUTE KIDNEY INJURY 676 0.0044
563 PERSONALITY CHANGE 41 0.0044
564 BEDRIDDEN 58 0.0044
565 HAIR TEXTURE ABNORMAL 59 0.0044
566 MULTIPLE SCLEROSIS RELAPSE 302 0.0044
567 RESPIRATORY DEPRESSION 54 0.0044
568 PHARYNGEAL SWELLING 43 0.0044
569 SHOCK 101 0.0044
570 FEEDING DISORDER 89 0.0044
571 ADVERSE EVENT 404 0.0044
572 PHARYNGITIS 54 0.0043
573 IMPAIRED WORK ABILITY 93 0.0043
574 FULL BLOOD COUNT ABNORMAL 46 0.0043
575 MUSCLE RIGIDITY 52 0.0043
576 NO THERAPEUTIC RESPONSE 53 0.0043
577 INTERVERTEBRAL DISC PROTRUSION 95 0.0043
578 RHABDOMYOLYSIS 181 0.0043
579 ELECTROCARDIOGRAM ABNORMAL 34 0.0043
580 FRUSTRATION TOLERANCE DECREASED 35 0.0043
581 UPPER RESPIRATORY TRACT INFECTION 200 0.0043
582 HIP ARTHROPLASTY 66 0.0043
583 MADAROSIS 50 0.0043
584 POST PROCEDURAL INFECTION 35 0.0043
585 OEDEMA 233 0.0043
586 OVERDOSE 925 0.0043
587 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 44 0.0043
588 HYSTERECTOMY 37 0.0043
589 THERAPEUTIC RESPONSE DECREASED 258 0.0043
590 MULTIPLE SCLEROSIS 203 0.0042
591 LIVER DISORDER 188 0.0042
592 FEAR 114 0.0042
593 NAUSEA 3349 0.0042
594 SKIN LACERATION 46 0.0042
595 NERVE COMPRESSION 39 0.0042
596 PERIPHERAL COLDNESS 58 0.0042
597 TENDERNESS 44 0.0042
598 PAIN 2577 0.0042
599 PARALYSIS 60 0.0042
600 INFUSION SITE PAIN 54 0.0042
601 VISUAL IMPAIRMENT 518 0.0042
602 QUALITY OF LIFE DECREASED 56 0.0042
603 RESPIRATORY RATE INCREASED 37 0.0042
604 PRODUCT PHYSICAL ISSUE 84 0.0042
605 POLYURIA 34 0.0041
606 PNEUMONIA 1343 0.0041
607 RASH 1807 0.0041
608 FATIGUE 3212 0.0041
609 DRUG ERUPTION 73 0.0041
610 INTENTIONAL PRODUCT MISUSE 360 0.0041
611 BRONCHITIS 304 0.0041
612 TOOTH INFECTION 54 0.0041
613 SCAR 70 0.0041
614 FEELING HOT 250 0.0041
615 HYPOCALCAEMIA 77 0.0041
616 DERMATITIS ALLERGIC 51 0.0041
617 ROTATOR CUFF SYNDROME 52 0.0040
618 HYPOAESTHESIA ORAL 61 0.0040
619 POISONING DELIBERATE 38 0.0040
620 STEVENS-JOHNSON SYNDROME 89 0.0040
621 LOSS OF CONSCIOUSNESS 512 0.0040
622 HEPATIC ENCEPHALOPATHY 37 0.0040
623 VISUAL ACUITY REDUCED 131 0.0039
624 KNEE ARTHROPLASTY 83 0.0039
625 GASTROENTERITIS VIRAL 71 0.0039
626 URINARY RETENTION 131 0.0039
627 NERVOUS SYSTEM DISORDER 122 0.0039
628 PARKINSONISM 38 0.0039
629 TACHYCARDIA 346 0.0039
630 GLAUCOMA 75 0.0039
631 ASTHENIA 1464 0.0039
632 MOUTH ULCERATION 82 0.0039
633 ARTHRALGIA 1612 0.0039
634 HYPOPHAGIA 99 0.0039
635 APHONIA 54 0.0039
636 SUPRAVENTRICULAR TACHYCARDIA 37 0.0039
637 MOVEMENT DISORDER 124 0.0039
638 ANAPHYLACTIC REACTION 213 0.0039
639 LYMPHOCYTE COUNT DECREASED 68 0.0038
640 BONE DISORDER 70 0.0038
641 KIDNEY INFECTION 75 0.0038
642 INSURANCE ISSUE 58 0.0038
643 THERAPEUTIC RESPONSE UNEXPECTED 170 0.0038
644 MENTAL STATUS CHANGES 105 0.0038
645 ADVERSE DRUG REACTION 338 0.0038
646 THERAPY CHANGE 37 0.0038
647 SPINAL PAIN 44 0.0038
648 CHEST PAIN 691 0.0037
649 NASAL CONGESTION 219 0.0037
650 DISEASE RECURRENCE 176 0.0037
651 EMOTIONAL DISORDER 114 0.0037
652 MICTURITION URGENCY 42 0.0037
653 LOSS OF LIBIDO 33 0.0037
654 BREAST PAIN 39 0.0037
655 SPINAL OPERATION 45 0.0036
656 DYSGEUSIA 271 0.0036
657 DRUG EFFECT LESS THAN EXPECTED 54 0.0036
658 ABDOMINAL PAIN 844 0.0036
659 SINUS CONGESTION 49 0.0036
660 LIMB DISCOMFORT 112 0.0036
661 ELECTROLYTE IMBALANCE 42 0.0036
662 PRODUCTIVE COUGH 172 0.0036
663 BRAIN NEOPLASM 33 0.0036
664 ERECTILE DYSFUNCTION 92 0.0036
665 POOR VENOUS ACCESS 37 0.0036
666 WHITE BLOOD CELL COUNT INCREASED 136 0.0035
667 INTENTIONAL DOSE OMISSION 101 0.0035
668 NEUROTOXICITY 62 0.0035
669 DYSURIA 130 0.0035
670 MALAISE 1538 0.0035
671 COAGULOPATHY 58 0.0035
672 FEELING ABNORMAL 829 0.0035
673 RESPIRATORY TRACT INFECTION 90 0.0035
674 PALPITATIONS 404 0.0034
675 GINGIVAL BLEEDING 47 0.0034
676 DIARRHOEA 2219 0.0034
677 RENAL FAILURE 456 0.0034
678 CARPAL TUNNEL SYNDROME 48 0.0034
679 MULTIPLE ORGAN DYSFUNCTION SYNDROME 97 0.0034
680 RASH MACULO-PAPULAR 76 0.0034
681 NERVOUSNESS 177 0.0034
682 ANHEDONIA 89 0.0034
683 OCULAR DISCOMFORT 38 0.0034
684 RENAL TUBULAR NECROSIS 33 0.0034
685 HYPOTENSION 674 0.0034
686 URINARY TRACT INFECTION 571 0.0033
687 FEELING COLD 93 0.0033
688 PRODUCT AVAILABILITY ISSUE 76 0.0033
689 INFECTION 481 0.0033
690 AKATHISIA 45 0.0033
691 RESPIRATORY DISTRESS 91 0.0033
692 FREQUENT BOWEL MOVEMENTS 89 0.0033
693 HYPOTHYROIDISM 105 0.0033
694 RASH PRURITIC 178 0.0033
695 CHOKING 64 0.0033
696 CHOLELITHIASIS 107 0.0033
697 TOOTHACHE 59 0.0033
698 ACCIDENTAL OVERDOSE 119 0.0032
699 AGRANULOCYTOSIS 60 0.0032
700 CYST 40 0.0032
701 HEART RATE DECREASED 113 0.0032
702 HAIR COLOUR CHANGES 40 0.0032
703 RESPIRATORY FAILURE 234 0.0032
704 SYNCOPE 319 0.0032
705 ANKYLOSING SPONDYLITIS 42 0.0032
706 EYE DISCHARGE 33 0.0032
707 CIRCULATORY COLLAPSE 54 0.0032
708 HEREDITARY ANGIOEDEMA 34 0.0032
709 OROPHARYNGEAL PAIN 293 0.0032
710 ORTHOSTATIC HYPOTENSION 55 0.0032
711 HEART RATE INCREASED 312 0.0031
712 PREMATURE BABY 94 0.0031
713 FLUSHING 317 0.0031
714 DRY EYE 155 0.0031
715 DYSPNOEA 1755 0.0031
716 VIRAL INFECTION 103 0.0031
717 LIP SWELLING 103 0.0031
718 HIATUS HERNIA 40 0.0031
719 INCREASED APPETITE 59 0.0031
720 SURGERY 181 0.0031
721 RESPIRATORY TRACT CONGESTION 49 0.0031
722 MUSCULOSKELETAL DISCOMFORT 53 0.0031
723 RHINORRHOEA 199 0.0031
724 PRODUCT DOSE OMISSION IN ERROR 87 0.0031
725 ILLNESS 313 0.0030
726 BURNING SENSATION 213 0.0030
727 THROAT TIGHTNESS 82 0.0030
728 BLOOD ALKALINE PHOSPHATASE INCREASED 75 0.0030
729 SKIN CANCER 65 0.0030
730 ACUTE RESPIRATORY FAILURE 58 0.0030
731 ACCIDENT 36 0.0030
732 CHROMATURIA 68 0.0030
733 FLUID RETENTION 153 0.0030
734 NODULE 39 0.0030
735 BACK PAIN 694 0.0030
736 LEUKOCYTOSIS 54 0.0030
737 PRODUCT PRESCRIBING ERROR 71 0.0030
738 ANKLE FRACTURE 46 0.0030
739 INFLUENZA 330 0.0030
740 PREMATURE DELIVERY 47 0.0029
741 MALNUTRITION 33 0.0029
742 CONSTIPATION 643 0.0029
743 HUNGER 41 0.0029
744 HYPERLIPIDAEMIA 35 0.0029
745 DYSPHAGIA 278 0.0029
746 WRIST FRACTURE 35 0.0029
747 ARTHRITIS 228 0.0029
748 PANCREATITIS 153 0.0029
749 FEELING JITTERY 55 0.0029
750 PRODUCT TASTE ABNORMAL 39 0.0029
751 ACTIVITIES OF DAILY LIVING IMPAIRED 57 0.0029
752 COVID-19 504 0.0029
753 PYREXIA 993 0.0029
754 EPISTAXIS 212 0.0028
755 PRODUCT DOSE OMISSION 185 0.0028
756 RECTAL HAEMORRHAGE 121 0.0028
757 RASH PAPULAR 63 0.0028
758 JOINT INJURY 60 0.0028
759 LYMPHADENOPATHY 99 0.0028
760 POLLAKIURIA 116 0.0028
761 DIVERTICULITIS 77 0.0028
762 PRODUCT DOSE OMISSION ISSUE 817 0.0028
763 THERAPY CESSATION 142 0.0028
764 TOXIC EPIDERMAL NECROLYSIS 42 0.0028
765 CYSTITIS 88 0.0028
766 BLOOD PRESSURE FLUCTUATION 66 0.0027
767 OXYGEN SATURATION DECREASED 154 0.0027
768 HEPATIC STEATOSIS 51 0.0027
769 CYANOSIS 43 0.0027
770 ORAL CANDIDIASIS 36 0.0027
771 FUNGAL INFECTION 91 0.0027
772 DEEP VEIN THROMBOSIS 176 0.0027
773 STAPHYLOCOCCAL INFECTION 89 0.0027
774 BLOOD URINE PRESENT 51 0.0027
775 GLOMERULAR FILTRATION RATE DECREASED 33 0.0027
776 PULMONARY MASS 40 0.0027
777 GASTRIC ULCER 51 0.0027
778 ARRHYTHMIA 127 0.0027
779 SNEEZING 60 0.0027
780 PRODUCT ADMINISTRATION ERROR 54 0.0027
781 CATARACT 159 0.0027
782 TRANSIENT ISCHAEMIC ATTACK 90 0.0027
783 HYPONATRAEMIA 150 0.0027
784 GAMMA-GLUTAMYLTRANSFERASE INCREASED 59 0.0027
785 HOSPITALISATION 407 0.0026
786 COUGH 739 0.0026
787 HAEMATOCRIT DECREASED 52 0.0026
788 DRUG EFFECT INCOMPLETE 95 0.0026
789 HAEMORRHOIDS 51 0.0026
790 INJECTION SITE URTICARIA 64 0.0026
791 EYE SWELLING 97 0.0026
792 CELLULITIS 131 0.0026
793 NEUROPATHY PERIPHERAL 246 0.0026
794 LABORATORY TEST ABNORMAL 76 0.0026
795 MUSCULOSKELETAL DISORDER 49 0.0026
796 AGEUSIA 64 0.0026
797 TOOTH DISORDER 57 0.0026
798 UPPER LIMB FRACTURE 51 0.0026
799 MULTIPLE FRACTURES 42 0.0026
800 EYE DISORDER 84 0.0026
801 INFLUENZA LIKE ILLNESS 210 0.0025
802 ACUTE RESPIRATORY DISTRESS SYNDROME 45 0.0025
803 THROAT IRRITATION 114 0.0025
804 PULMONARY EMBOLISM 241 0.0025
805 OEDEMA PERIPHERAL 309 0.0025
806 MUSCLE TIGHTNESS 41 0.0025
807 PAIN OF SKIN 68 0.0025
808 PROCEDURAL PAIN 70 0.0025
809 BLOOD PRESSURE DECREASED 167 0.0025
810 PALLOR 68 0.0025
811 PRURITUS GENERALISED 54 0.0025
812 SPINAL FRACTURE 50 0.0025
813 ALANINE AMINOTRANSFERASE INCREASED 153 0.0025
814 MULTI-ORGAN FAILURE 43 0.0025
815 RETCHING 53 0.0025
816 BLOOD PRESSURE SYSTOLIC INCREASED 48 0.0025
817 BRONCHOSPASM 35 0.0025
818 LIVER FUNCTION TEST ABNORMAL 71 0.0024
819 SKIN DISCOLOURATION 112 0.0024
820 HEPATOTOXICITY 54 0.0024
821 DEHYDRATION 322 0.0024
822 CHEST DISCOMFORT 247 0.0024
823 LYMPHOPENIA 34 0.0024
824 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 125 0.0024
825 LIMB INJURY 65 0.0024
826 PRURITUS 914 0.0024
827 HERPES ZOSTER 136 0.0024
828 PAIN IN JAW 67 0.0024
829 UNEVALUABLE EVENT 178 0.0024
830 PSORIASIS 307 0.0023
831 BLOOD PRESSURE INCREASED 359 0.0023
832 HEART RATE IRREGULAR 53 0.0023
833 PRODUCT DISPENSING ERROR 51 0.0023
834 ERUCTATION 45 0.0023
835 ULCER 37 0.0023
836 THERAPEUTIC RESPONSE SHORTENED 77 0.0023
837 CONJUNCTIVITIS 43 0.0023
838 PELVIC PAIN 42 0.0023
839 GALLBLADDER DISORDER 41 0.0023
840 DRUG DISPENSING ERROR 35 0.0023
841 LACRIMATION INCREASED 69 0.0023
842 RASH ERYTHEMATOUS 109 0.0023
843 PRESYNCOPE 55 0.0023
844 TENDONITIS 35 0.0023
845 INTESTINAL OBSTRUCTION 85 0.0023
846 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 406 0.0023
847 RASH GENERALISED 58 0.0022
848 THERAPY INTERRUPTED 160 0.0022
849 BONE PAIN 131 0.0022
850 PANCREATITIS ACUTE 50 0.0022
851 DEAFNESS 58 0.0022
852 COLD SWEAT 39 0.0022
853 THROMBOCYTOPENIA 247 0.0022
854 GASTRITIS 58 0.0022
855 ANGINA PECTORIS 63 0.0022
856 LEUKOPENIA 109 0.0022
857 HOT FLUSH 163 0.0022
858 BLOOD PRESSURE ABNORMAL 43 0.0022
859 PRODUCT USE COMPLAINT 34 0.0022
860 PRODUCT PRESCRIBING ISSUE 47 0.0022
861 DERMATITIS 45 0.0021
862 MYALGIA 364 0.0021
863 VENTRICULAR TACHYCARDIA 35 0.0021
864 HYPOACUSIS 91 0.0021
865 FRACTURE 40 0.0021
866 ABASIA 52 0.0021
867 ABNORMAL DREAMS 58 0.0021
868 ORAL PAIN 47 0.0021
869 ASPARTATE AMINOTRANSFERASE INCREASED 111 0.0021
870 OCULAR HYPERAEMIA 99 0.0021
871 SKIN LESION 57 0.0021
872 HERNIA 40 0.0021
873 TARDIVE DYSKINESIA 58 0.0021
874 HAEMATOMA 53 0.0020
875 HYPOXIA 72 0.0020
876 SEPSIS 228 0.0020
877 SKIN DISORDER 68 0.0020
878 NEEDLE ISSUE 59 0.0020
879 RENAL DISORDER 94 0.0020
880 FACE OEDEMA 34 0.0020
881 THROMBOSIS 161 0.0020
882 HYPOGLYCAEMIA 97 0.0020
883 ORAL HERPES 39 0.0020
884 EYE IRRITATION 115 0.0020
885 EOSINOPHILIA 35 0.0020
886 DYSPNOEA EXERTIONAL 75 0.0020
887 POST PROCEDURAL COMPLICATION 38 0.0020
888 PULMONARY HYPERTENSION 41 0.0020
889 DRUG EFFECT DECREASED 106 0.0020
890 GASTRIC DISORDER 66 0.0019
891 INJECTION SITE MASS 71 0.0019
892 DIABETES MELLITUS 145 0.0019
893 HEPATIC FAILURE 57 0.0019
894 CHILLS 221 0.0019
895 TOOTH LOSS 39 0.0019
896 FLATULENCE 106 0.0019
897 PERICARDIAL EFFUSION 43 0.0019
898 INTERNATIONAL NORMALISED RATIO INCREASED 53 0.0019
899 SKIN ULCER 48 0.0019
900 SEPTIC SHOCK 80 0.0018
901 WHITE BLOOD CELL COUNT DECREASED 198 0.0018
902 DERMATITIS ATOPIC 96 0.0018
903 INTENTIONAL DRUG MISUSE 38 0.0018
904 EYE PRURITUS 61 0.0018
905 PULMONARY OEDEMA 81 0.0018
906 BLOOD SODIUM DECREASED 34 0.0018
907 HIP FRACTURE 58 0.0018
908 HEPATIC FUNCTION ABNORMAL 67 0.0018
909 CLOSTRIDIUM DIFFICILE INFECTION 39 0.0018
910 EMOTIONAL DISTRESS 216 0.0018
911 VAGINAL HAEMORRHAGE 77 0.0018
912 RASH MACULAR 62 0.0018
913 SKIN FISSURES 34 0.0017
914 LOCALISED INFECTION 42 0.0017
915 WRONG TECHNIQUE IN DRUG USAGE PROCESS 62 0.0017
916 HAEMATEMESIS 43 0.0017
917 INJECTION SITE RASH 52 0.0017
918 RENAL IMPAIRMENT 142 0.0017
919 PLATELET COUNT DECREASED 179 0.0017
920 INJECTION SITE PRURITUS 112 0.0017
921 INJECTION SITE BRUISING 133 0.0017
922 DRUG DOSE OMISSION 272 0.0016
923 DRUG WITHDRAWAL SYNDROME 143 0.0016
924 TRANSAMINASES INCREASED 36 0.0016
925 DEMENTIA 45 0.0016
926 NEUTROPENIA 216 0.0016
927 SKIN EXFOLIATION 134 0.0016
928 ERYTHEMA 325 0.0016
929 INCORRECT DOSE ADMINISTERED 357 0.0016
930 COLITIS 59 0.0016
931 INJECTION SITE SWELLING 119 0.0016
932 RED BLOOD CELL COUNT DECREASED 44 0.0015
933 CARDIAC DISORDER 139 0.0015
934 HAEMORRHAGE 153 0.0015
935 ABDOMINAL PAIN LOWER 37 0.0015
936 RENAL FAILURE ACUTE 62 0.0015
937 COLITIS ULCERATIVE 65 0.0015
938 INJECTION SITE ERYTHEMA 180 0.0014
939 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 290 0.0014
940 MENSTRUATION IRREGULAR 38 0.0014
941 CEREBROVASCULAR ACCIDENT 239 0.0014
942 HAEMOPTYSIS 39 0.0014
943 ANAEMIA 265 0.0014
944 CEREBRAL HAEMORRHAGE 49 0.0014
945 INJECTION SITE PAIN 417 0.0014
946 FEMUR FRACTURE 42 0.0014
947 DRY SKIN 181 0.0014
948 ACNE 101 0.0013
949 ASCITES 39 0.0013
950 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 94 0.0013
951 HYPERGLYCAEMIA 48 0.0013
952 BLOOD CREATININE INCREASED 86 0.0013
953 INJECTION SITE HAEMORRHAGE 105 0.0013
954 HAEMATURIA 45 0.0013
955 HAEMOGLOBIN DECREASED 134 0.0013
956 NEOPLASM MALIGNANT 87 0.0013
957 CARDIOVASCULAR DISORDER 33 0.0013
958 ECZEMA 68 0.0013
959 HYPERKALAEMIA 45 0.0013
960 DRUG DEPENDENCE 205 0.0013
961 ACUTE MYOCARDIAL INFARCTION 37 0.0013
962 BONE DENSITY DECREASED 39 0.0012
963 EXPIRED PRODUCT ADMINISTERED 41 0.0012
964 DEVICE BREAKAGE 50 0.0012
965 DEVICE DISLOCATION 53 0.0012
966 PANCYTOPENIA 68 0.0012
967 HAEMATOCHEZIA 67 0.0012
968 NO ADVERSE EVENT 217 0.0012
969 GASTROINTESTINAL HAEMORRHAGE 99 0.0012
970 PLEURAL EFFUSION 69 0.0011
971 PRODUCT ADHESION ISSUE 40 0.0011
972 BLOOD GLUCOSE DECREASED 52 0.0011
973 NEUTROPHIL COUNT DECREASED 44 0.0011
974 DEVICE MALFUNCTION 74 0.0011
975 CARDIAC FAILURE CONGESTIVE 83 0.0010
976 SKIN BURNING SENSATION 73 0.0010
977 BLOOD GLUCOSE INCREASED 190 0.0010
978 ATRIAL FIBRILLATION 95 0.0010
979 ACCIDENTAL EXPOSURE TO PRODUCT 98 0.0009
980 MYOCARDIAL INFARCTION 164 0.0009
981 CARDIAC FAILURE 74 0.0009
982 SKIN IRRITATION 42 0.0009
983 DISEASE PROGRESSION 108 0.0009
984 DEATH 772 0.0009
985 DEVICE ISSUE 79 0.0009
986 INTERSTITIAL LUNG DISEASE 38 0.0008
987 FEBRILE NEUTROPENIA 49 0.0007
988 DEVICE DIFFICULT TO USE 45 0.0007
989 BREAST CANCER 63 0.0007
990 DRUG DOSE OMISSION BY DEVICE 51 0.0007
991 DEVICE EXPULSION 38 0.0006
992 PRODUCT STORAGE ERROR 48 0.0005